期刊文献+

Homocysteine and IgA nephropathy: observational and Mendelian randomization analyses 被引量:8

原文传递
导出
摘要 Background:High levels of plasma homocysteine occur almost uniformly in patients with end-stage renal disease(ESRD).IgA nephropathy(IgAN)is the most common form of primary glomerulonephritis and a common cause of ESRD in young adults.Here,we aimed to detect whether homocysteine was elevated and associated with clinical-pathologic manifestations of IgAN patients and tested its causal effects using a two-sample Mendelian randomization(MR)approach.Methods:For observational analysis,108 IgAN patients,30 lupus nephritis(LN)patients,50 minimal change disease(MCD)patients,and 206 healthy controls were recruited from April 2014 to April 2015.Their plasma homocysteine was measured and clinical-pathologic manifestations were collected from medical records.For MR analysis,we further included 1686 IgAN patients.The missense variant methylenetetrahydrofolate reductase C677T(rs1801133)was selected as an instrument,which was genotyped by TaqMan allele discrimination assays.Results:Majority of IgAN patients(93.52%,101/108)showed elevated levels of plasma homocysteine(>10μmol/L).Plasma homocysteine in IgAN patients was significantly higher than that in MCD patients(median:18.32 vs.11.15μmol/L,Z=-5.29,P<0.01)and in healthy controls(median:18.32 vs.10.00μmol/L,Z=-8.76,P<0.01),but comparable with those in LN patients(median:18.32 L vs.14.50μmol/L,Z=-1.32,P=0.19).Significant differences were observed in sub-groups of IgAN patients according to quartiles of plasma homocysteine for male ratio(22.22%vs.51.85%vs.70.37%vs.70.37%,χ2=14.29,P<0.01),serum creatinine(median:77.00 vs.100.00 vs.129.00 vs.150.00μmol/L,χ2=34.06,P<0.01),estimated glomerular filtration rate(median:100.52 vs.74.23 vs.52.68 vs.42.67 mL·min-1·1.73 m-2,χ2=21.75,P<0.01),systolic blood pressure(median:120.00 vs.120.00 vs.125.00 vs.130.00 mmHg,χ2=2.97,P=0.05),diastolic blood pressure(median 80.00 vs.75.00 vs.80.00 vs.81.00 mmHg,χ2=11.47,P<0.01),and pathologic tubular atrophy and interstitial fibrosis(T)(T0/T1/T2:62.96%/33.33%/3.70%vs.29.63%/40.74%/29.63%vs.24.00%/48.00%/28.00%vs.14.81%/37.04%/48.15%,χ2=17.66,P<0.01).The coefficient of each rs1801133-T allele on homocysteine levels after controlling age and sex was 7.12(P<0.01).MR estimates showed causal positive effects of homocysteine on serum creatine(β=0.76,P=0.02),systolic blood pressure(β=0.26,P=0.02),diastolic blood pressure(β=0.20,P=0.01),and pathologic T lesion(β=0.01,P=0.01)in IgAN.Conclusions:By observational and MR analyses,consistent results were observed for associations of plasma homocysteine with serum creatinine,blood pressures,and pathologic T lesion in IgAN patients.
机构地区 Renal Division
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第3期277-284,共8页 中华医学杂志(英文版)
基金 This work was supported by grants from the Beijing Natural Science Foundation(No.7184253),and the National Natural Science Foundation of China(No.81800636).
  • 相关文献

参考文献1

二级参考文献21

  • 1Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab InvestigJ Tech Method Pathol 2001; 81: 645-672.
  • 2Sibrian-Vazquez M, Escobedo JO, Lira S, Samoei GK, Strongin RM. Homocystamides promote free-radical and oxidative damage to proteins. Proc Nat Acad Sci U S A 2010; 107: 551- 554.
  • 3Wu CC, Zheng CM, Lin YF, Lo L, Liao MT, Lu KC. Role of homocysteine in end-stage renal disease. Clin Biochem 2012; 45: 1286-1294.
  • 4Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379: 815-822.
  • 5Cai GY, Chen XM. lmmunoglobulin A nephropathy in China: progress and challenges. Am J Nephro12009; 30: 268-273.
  • 6Mestecky J, Raska M, Julian BA, Gharavi AG, Renfrow MB, Moldoveanu Z, et al. IgA nephropathy: molecular mechanisms of the disease. Ann Rev Patho12013; 8: 217-240.
  • 7Floege J. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches? Am J Kidney Dis J Nat Kidney Found 2011; 58: 992-1004.
  • 8Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, Imai E, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int 201 1; 79: 555-562.
  • 9Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76: 534-545.
  • 10Reich HN, Troyanov S, Scholey JW, Cattran DC. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol: JASN. 2007; 18: 3177-3183.

共引文献9

同被引文献34

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部